As discussed above, the combined p19Arf + IFNβ gene transfer approach triggered cell death mechanisms with remarkable immunogenic features, leading to reduced tumor burden and increased survival in animal models, which are desirable characteristics for any cancer therapeutics in development. Here, IFNB1 is linked to cancer.